View Older Stories View More Recent Stories
-
Investor pessimism mounts as more Fed rate hikes loom
-
Investor pessimism mounts as more Fed rate hikes loom
-
Investor pessimism mounts as more Fed rate hikes loom
-
Investor pessimism mounts as more Fed rate hikes loom
-
Investor pessimism mounts as more Fed rate hikes loom
-
Investor pessimism mounts as more Fed rate hikes loom
-
Investor pessimism mounts as more Fed rate hikes loom
-
Investor pessimism mounts as more Fed rate hikes loom
-
Equinor posts record profit as gas prices soar in Europe
-
Form MA/A RBC Capital Markets,
-
R1 RCM to Present at Upcoming Investor Conferences
-
Spruce Biosciences to Participate in May Investor Conferences
-
Acadia Pharmaceuticals to Present at Upcoming Investor Conferences
-
Sangamo BioSciences (SGMO) Partner Pfizer Announced Hemophilia-A Clinical Hold Lifted, 'A Clear Positive for SGMO' - RBC
-
RBC Capital on Sangamo BioSciences (SGMO): 'hold being lifted is a clear positive'
-
Edgewise Therapeutics to Present at Upcoming Investor Conferences
-
89bio to Participate in Upcoming Investor Conferences
-
Aptose to Present at 2022 RBC Capital Markets Global Healthcare Conference
-
Biogen CEO to step down; drugmaker pulls back on Alzheimer's drug Aduhelm
-
HOOKIPA Pharma to Participate in Upcoming Investor Conferences in May
-
HOOKIPA Pharma to Participate in Upcoming Investor Conferences in May
-
RBC Capital Sees Wayfair (W) Having a Challenging Setup into the Quarter, Estimates Cut
-
Karuna Therapeutics to Present at the 2022 RBC Capital Markets Global Healthcare Conference
-
Expedia (EXPE) PT Lowered to $185 at RBC Capital After Mixed Quarterly Report
-
Portugal's Galp quarterly profit surges, but still misses forecast
-
Imperial announces terms of its substantial issuer bid for up to $2,500,000,000
-
HCA Healthcare, Inc. to Present at May Healthcare Conferences
-
GoodRx to Present at the RBC Capital Markets 2022 Global Healthcare Conference
-
eFFECTOR Therapeutics to Participate in Upcoming Investor Conferences
-
Thorne HealthTech to Participate in Upcoming Investor Conferences in May
-
Arrowhead Pharmaceuticals to Participate in Upcoming May 2022 Conferences
-
nVent Electric (NVT) PT Raised to $41 at RBC Capital on Strong Organic Beat and Conservative Guidance
-
PTC Therapeutics to Participate at Upcoming Investor Conferences
-
Exxon, Chevron post big revenues, but Wall Street shrugs
-
UPDATE: Amazon.com (AMZN) PT Lowered to $3,500 at RBC Capital on Weak 2Q Guidance
-
Amedisys to Present at Multiple Healthcare Conferences in May
-
Stericycle (SRCL) Results Pressured by Delay of Enacting Fuel Surcharges, RBC Capital Reiterates Outperform
-
Hershey (HSY) PT Raised to $237 at RBC Capital After Posting a Strong Beat and Conservative Guide
-
UPDATE: RBC Capital Starts Constellation Energy (CEG) at Outperform
-
UNIVERSAL HEALTH SERVICES, INC. TO PRESENT AT MAY HEALTHCARE CONFERENCES
-
Orchid Island Capital Announces First Quarter 2022 Results
-
T-Mobile US, (TMUS) Remains a Safe Place to Hide - RBC Capital
-
Tech Giants Commit Nearly $1 Billion Toward Carbon Capture
-
Crown Holdings (CCK) PT Raised to $143 at RBC Capital
-
Chubb Corporation (CB) PT Raised to $243 at RBC Capital Following Earnings
-
impact.com Announces Secondary Investment from W Capital and Providence Public of Approximately $100 Million
-
Sorenson Ventures Expands Investment Team
-
UPDATE: RBC Capital Downgrades Potlatch (PCH) to Sector Perform
-
Europe decries 'blackmail' as Russia cuts gas to Poland, Bulgaria
-
Anglo Pacific Group PLC Announces Q1 2022 Trading Update
